Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF‐2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma. The gene discussed is EPAS1; the disease is hereditary clear cell renal cell carcinoma.